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Introduction. The aim of the present study was to evaluate the eﬀects of fetal sex on serum human chorionic gonadotropin (hCG)
and testosterone in normotensive and preeclamptic pregnancies. Materials and Methods. This is a cross-sectional study and 139
women with singleton pregnancies in the third trimester were studied. Seventy-one pregnancies were uncomplicated; among
those were 35 male and 36 female fetuses. Sixty-eight pregnancies were complicated by preeclampsia; among those were 35 male
and 33 female fetuses. Human chorionic gonadotropin and total testosterone were measured in maternal peripheral blood. Data
analyzed by SPSS software. Results. In male-bearing pregnancies, maternal hCG and testosterone serum levels were signiﬁcantly
higher in preeclamptic than normotensive mothers (P<0.001 and P<0.001, resp.) in female-bearing pregnancies testosterone
levels were signiﬁcantly higher in preeclamptic than normotensive mothers (P<0.001). Total testosterone levels were signiﬁcantly
higher in pregnancies with either gender and signiﬁcantly higher in mlae-bearing than in female-bearing pregnancies. Conclusion.
According to our results, there is a correlation between maternal serum hCG and testosterone levels and preeclampsia. Therefore
these tests can be used as routine during 30–38 weeks of gestation. High maternal serum concentrations of these markers can
predict preeclampsia.
1.Introduction
Following the inﬂammation cascade, placenta produces
some peptides that might be valuable as predictive markers
of preeclampsia. Some studied peptides in this ﬁeld include
corticotrophin-releasing hormone (CRH, hCG), human
chorionic gonadotropin, activin A, and inhibin A. Since
the disease is resolved soon after delivery, most attention
is focused on fetus, placenta, and fetal membranes. hCG
concentration in maternal blood is 100 U/L during miss
period. At 8–10 weeks of gestation, hCG level rises to a
peak of 100,000 U/L, then drops down to 10000–20000
U/L at 18–20 weeks and reaches a plateau for the rest of
the pregnancy [1]. During the ﬁrst and second trimesters
of normal pregnancy, there are no gender diﬀerences in
maternal hCG levels. However, from the second to the
third trimesters, there is a marked shift in maternal hCG
serum concentrations. The hCG levels in female-bearing
pregnancies increase signiﬁcantly, whereas they decrease
in male-bearing pregnancies [1–3]. Maternal serum con-
centration of total testosterone (TT) increases gradually
throughout pregnancy, whereas free testosterone (FT) levels
change very little until the third trimester and then become
double. The sources for the increased testosterone levels in
maternalserumareunknownbutcouldbetheovariantheca-
interstitial cells and the maternal cortex, which might be
stimulated by hCG throughout pregnancy [4].
Gurbuz et al. in a study in 2004 found that the maternal
serum hCG level is a useful laboratory tool when managing
and treating hypertensive disorders that complicate preg-
nancy [5]. An increased level of serum hCG is found in
mothers with pregnancies complicated by preeclampsia. On
the other hand, testosterone levels have been shown to be
signiﬁcantlyhigherinpreeclampticpregnanciesthannormal2 Journal of Pregnancy
pregnancies [6–8]. Steier et al. in a study in 2002 found
that in male-bearing pregnancies maternal serum hCG and
testosterone levels are signiﬁcantly higher in preeclamptic
mothers than normotensive mothers [2, 9–11]. Gol et al. in
2004 found that hCG concentration in maternal serum and
cordblood is signiﬁcantly higher in normal pregnancies with
female than male fetuses [3, 12]. Elsm´ en et al. concluded
that mean serum hCG level in male-carrying pregnancies
was signiﬁcantly higher in preeclamptic pregnancies than in
normal pregnancies [13]. Due to these limited data about
the relationship between fetal gender and preeclampsia, this
study was undertaken to investigate the eﬀects of fetal gender
onmaternalserumconcentrationofhCGandtestosteronein
normotensive and preeclamptic pregnancies.
2.MaterialsandMethods
All pregnant women admitted to our outpatient obstetric
clinic of Haj Asali Hospital for pregnancy visits from 23
October 2008 to 22 September 2009 were enrolled in
this cross-sectional study. All women underwent routine
pregnancy examinations, and if they had a blood pressure
equal to or higher than 140/90mmHg, urine analyses
were requested to detect proteinuria. Women who had a
proteinuria between trace to 2+ and without any signs
and symptoms of severe preeclampsia were considered as
mild-to-moderate preeclampsia. Pregnancies with severe
preeclampsia did not enter the study. Pregnancies with
gestational diabetes and fetal anomalies were also excluded
from the study. Finally a total of 139 mothers met the criteria
to enter the study.
Of the 139 women in the study, 68 were preeclamptic
and71werenormotensive.Amongpreeclampticpregnancies
were 35 male fetuses and 33 female fetuses. Of the 71
normal pregnancies, 35 were male bearing and 36 were
female bearing. All pregnancies were at 30–38 weeks of
gestation. The study was approved by the Ethical Institu-
tional Committee of Lorestan University. Written informed
consent was obtained from all participants. The including
criteria was the patients who were primigravid, had third
trimester pregnancy, BP = 140/90mmHg, and proteinuria =
300mg in a 24h urine sample. Patients with renal diseases,
chronic hypertension, renal and urinary infection, fetal dis-
orders, multiple pregnancy, and immunologic diseases were
excluded from the study. Pregnant women without the above
criteria were considered as control group. A questionnaire
was completed for each patient including patient’s age,
gestational age, parity, the history of hypertension, diabetes
mellitus, hypertension in family, diabetes mellitus in family,
and tobacco consumption. After taking informed consents
from all pregnant women who entered the study, they were
examined physically. Blood pressure and urine specimens
were collected, and detailed ultrasonographic structural
examinations of the fetuses were performed. Simultaneously,
blood samples were drawn from an antecubital maternal
vein prior to delivery at the time of admission (30–38wk of
gestation) for examination of hCG and total testosterone. A
t o t a lo f1 0C Cp e r i p h e r a lv e n o u sb l o o dw a st a k e nf r o me a c h
woman and sent to the central laboratory of Asali Hospital.
Venous blood was collected by venepuncture in 10mL
silicone-coated Vacutainer blood-collecting tubes containing
no additives between 7:00 AM and 9:00 AM in a fasting state.
Blood was allowed to clot at room temperature and was then
centrifuged for 20 minutes at 2000g. Aliquots of the serum
were then stored at −20◦C until they were required for the
assay.
Consistent with the deﬁnition of the ACOG, preeclamp-
sia was deﬁned as new-onset hypertension after 20 weeks
of gestation, with a diastolic blood pressure of 90mmHg
or higher with concurrent proteinuria of 300mg/24 hours
or greater. Semiquantitative dipstick tests were used for
measurement of proteinuria (1+ and 2+ corresponded to
300mg/24 hours and 500mg/24 hours, resp.). 10 human
chorionic gonadotropin were measured by immunoradio-
metric assay (hCG IRMA KIT, IMMUNOTEC as Radova
Prague). The Third International Standard for hCG was used
as a reference standard. The assay has a detection limit of
3IU/L. The intra-assay coeﬃcient of variation was 3.3 and
7.0 for mean hCG levels at 21 and 1500IU/L, respectively.
The interassay coeﬃcient of variation was 7.2 and 9.1 for
hCG levels at 21 and 1500IU/L, respectively.
TestosteronelevelwasdeterminedbyaDRGTestosterone
Eliza Kit (DRG Instruments GmbH, Germany). The test
is based on a radioimmunoassay technique. The expected
serumtestosteronelevelsrangedbetween0.3and2.8nmol/L.
The sensitivity was 0.1nmol/L. The intra-assay coeﬃcient
of variation was 7.5 and 5.5 for testosterone levels at 1.6
and 26.5nmol/L, respectively. The interassay coeﬃcient of
variation was 7.0 and 4.8 for testosterone levels at 1.2 and
23.3nmol/L, respectively.
2.1. Statistical analysis. Laboratory tests results and other
data (such as maternal age, gestational age, parity, type
of pregnancy, systolic blood pressure, and diastolic blood
pressure) were gathered in a questionnaire. Statistical anal-
yses were performed using t-test and unparametric tests as
appropriate, with statistical signiﬁcance considered at P<
0.05. Data are presented as mean with standard error and
95% conﬁdence interval (CI). SPSS version 15 was used to
analyze the data.
3. Results
A total of 139 women with singleton pregnancies at 30–38
weeks of gestation entered the study. Maternal age was 14–
38 years old, and parity was 0–3. In preeclamptic group,
diastolic blood pressure was 90–110mmHg and systolic
blood pressure was 140–155mmHg, and no diﬀerence was
foundbetweenmaleandfemalefetuses(Table 1).Proteinuria
was determined between +1 and +2, and it was not
diﬀerent between male and female fetuses. Mean serum
hCG level was 16337 ± 2462U/L in male-bearing normal
pregnancies and 28774±3197U/L in female-bearing normal
pregnancies. A statistically signiﬁcant diﬀerence was found
between the two mean values using t-test (P<0.005).
Mean serum hCG level was 31610 ± 3825U/L in male-
bearing preeclamptic pregnancies and 34480 ± 4559U/L in
female- bearing preeclamptic pregnancies. No signiﬁcantJournal of Pregnancy 3
Table 1: Comparison of the clinical characteristics in normal and preeclamptic pregnancies with male and female fetuses.
Type of pregnancy Normal Preeclamptic
Fetal gender Male Female Male Female
Maternal age (year) Range 14–38 17–28 14–39 15–36
Mean ± SEM∗ 22.9 ±0.92 1 .2 ±0.52 2 .7 ± 1.22 2 .5 ±0.9
Parity (n) Range 0–3 0–2 0–3 0–3
Mean ± SEM 0.9 ±0.20 .6 ±0.10 .5 ±0.10 .5 ± 0.1
Gestational age (wk) Range 30–37 31–37 30–38 30–37
Mean ± SEM 33.5 ±0.43 3 .9 ±0.33 4 .1 ± 0.43 3 .7 ±0.4
Systolic blood pressure (mmHg) Range 100–130 95–130 140–155 140–155
Mean ± SEM 115.9 ±1.6 113.5 ±1.4 144.9 ±0.8 145.5 ±0.8
Diastolic blood pressure (mmHg) Range 65–85 60–85 90–100 90–100
Mean ± SEM 72.6 ±1.27 0 .6 ±1.19 2 .7 ± 0.59 2 .9 ±0.5
∗SEM: standard error of the mean.
Table 2: Comparison of mean serum hCG level in normal and preeclamptic pregnancies with male and female fetuses.
Type of pregnancy Normal Preeclamptic
P value
Fetal gender Number hCG (mean ± SEM) Number hCG (mean ± SEM)
Male 35 16337 ±313 35 31610 ±355 <0.001
Female 36 28774 ±326 33 34480 ±470 NS
P value <0.005 NS
diﬀerence was found between the two mean values using
t-test (NS) (Table 2). Mean serum testosterone level in
normal pregnancies was 2.85 ± 0.33nmol/L for male fetuses
and 2.50 ± 0.25nmol/L for female fetuses. t-test showed
no signiﬁcant diﬀerence between the two mean values
(NS). In pregnancies complicated with preeclampsia, mean
serum testosterone level was 5.86 ± 0.78nmol/L in male-
carrying pregnancies and 3.92 ± 0.40nmol/L in female-
carrying pregnancies. The diﬀerence between mean values
was statistically signiﬁcant using t-test (P<0.001) (Table 3).
Mean serum hCG level in male-bearing pregnancies was
signiﬁcantly higher in preeclamptic (16337 ± 2462U/L)
than in normotensive pregnancies (31610 ± 3825) (P<
0.001) (Table 2). Mean serum hCG level in female-bearing
pregnancies was not signiﬁcantly diﬀerent between nor-
motensive (28774 ± 3197U/L) and preeclamptic (34480 ±
4559U/L) groups. Mean serum testosterone level in male-
bearing pregnancies was signiﬁcantly higher in preeclamptic
group (2.85 ± 0.33nmol/L) than in normotensive group
(5.86 ± 0.78nmol/L) (P<0.001). Mean serum testosterone
level in normotensive pregnancies with male fetus (2.50 ±
0.25nmol/L) was found to be signiﬁcantly lower than in
female-bearing pregnancies complicated with preeclampsia
(3.92 ± 0.40nmol/L) (P<0.001) (Table 3). Mean hCG
serum level without considering fetus gender was shown
to be 22643 ± 776U/L in normal pregnancies and 33003 ±
339U/L in preeclamptic pregnancies. The diﬀerence was
shown signiﬁcant using t-test (P<0.001) (Table 4). Mean
serum testosterone level without considering fetus sex was
reported 2.67 ± 0.03nmol/L in normal pregnancies and
4.92 ±0.12nmol/L for preeclamptic pregnancies (Table 5).
4. Discussion
These results are consistent with previous studies which
also indicated that there is no gender diﬀerence in maternal
serum hCG level during the ﬁrst and second trimesters of
pregnancy, but there is a shift from second to third trimester
so that hCG levels signiﬁcantly increase in female-bearing
pregnancies and decrease in male-bearing pregnancies [9].
In a study by the American Association of Obstetricians and
Gynecologists, it was reported that, in normal pregnancies,
maternal serum hCG level is signiﬁcantly higher in female-
bearing pregnancies than in male-bearing pregnancies [12].
Several studies have found elevated hCG concentrations in
maternal blood in preeclamptic pregnancies but without
regard to fetal gender. Gurbuz et al. in a study in 2004 found
that the maternal serum hCG level is a useful laboratory
tool when managing and treating hypertensive disorders
that complicate pregnancy. The serum hCG level is espe-
cially signiﬁcant in severe preeclampsia and superimposed
preeclampsia. Therefore, a high serum hCG level can be a
helpful marker in the diagnosis and clinical management
by preventing possible complications resulting from severe
and superimposed preeclampsia [5]. In a study in Iran from
2001 to 2005, Basirat et al. found that maternal serum hCG
level was signiﬁcantly higher in preeclamptic pregnancies
in comparison with normal pregnancies (P = 0.031) [6].
Bartha et al. in 2003 also indicated increased levels of
maternal serum hCG in preeclamptic compared to normal
pregnancies [14]. In the present study, the hCG levels in
maternal blood in male-bearing preeclamptic pregnancies
weresigniﬁcantlyhighercomparedwiththatinmale-bearing4 Journal of Pregnancy
Table 3: Comparison of mean serum testosterone level in normal and preeclamptic pregnancies with male and female fetuses.
Type of pregnancy Normal Preeclamptic
P value
Fetal gender Number Tes. (mean ± SEM) Number Tes. (mean ± SEM)
Male 35 2.85 ±0.03 35 5.86 ±0.05 <0.001
Female 36 2.50 ±0.02 33 3.92 ±0.03 <0.001
P value NS <0.001
Table 4: Comparison of mean serum hCG level between normal
and preeclamptic pregnancies.
Type of pregnancy Number hCG (mean ± SEM) P value
Normal 71 22643 ± 776
<0.001 Preeclamptic 68 33003 ± 339
Total 139 27711 ± 614
Table 5: Comparison of mean serum testosterone level between
normal and preeclamptic pregnancies.
Type of pregnancy Number Testosterone
(mean ± SEM) P value
Normal 71 2.67 ±0.03
Preeclamptic 68 4.92 ±0.12 <0.001
Total 139 3.77 ±0.11
uncomplicated pregnancies, whereas in preeclampsia with
female fetuses no signiﬁcant increase in the maternal hCG
level was observed. In a study in Turkey (2005), it was
found that maternal serum hCG level at 24–28 weeks and
32–36 weeks of gestation is signiﬁcantly higher in female-
carrying pregnancies than male-bearing pregnancies (P<
0.004 and P<0.001, resp.) [12]. Steier et al. in a study
in 2002 found that in male-bearing pregnancies maternal
serum hCG and testosterone levels are signiﬁcantly higher in
preeclamptic mothers than in normotensive mothers (P<
0.001). In female-bearing pregnancies, testosterone level
was signiﬁcantly higher in preeclamptic than normotensive
mothers whereas hCG levels were not signiﬁcantly diﬀerent.
Maternal serum levels of testosterone were signiﬁcantly
higher in preeclamptic pregnancies with male fetuses than
with female fetuses (P<0.001), whereas hCG levels were
not signiﬁcantly diﬀerent. In normal pregnancies, female-
bearing pregnancies had signiﬁcantly higher serum hCG
levels than male-bearing pregnancies (P<0.005), whereas
testosteronelevelswerenotsigniﬁcantlydiﬀerent[9].Elsm´ en
et al. concluded that mean serum hCG level in male-
carryingpregnancieswassigniﬁcantlyhigherinpreeclamptic
pregnancies than in normal pregnancies [13]. This ﬁnding
was consistent with the study in America in which serum
hCG level was found to be signiﬁcantly higher in male-
bearing pregnancies complicated with preeclampsia than
normal ones (P<0.001).
In the present study, mean serum hCG level was not
signiﬁcantly diﬀerent between normal and preeclamptic
pregnancies with female fetuses which was inconsistent with
the results of the American Association of Obstetricians and
Gynecologists. In fact, high maternal serum concentration
of hCG in female-bearing pregnancies is not indicative of
preeclampsia since this increment is also seen in normal
pregnancies, whereas, in male-carrying pregnancies, high
maternal serum levels of hCG can be a marker to predict
preeclampsia. Mean serum hCG level was not signiﬁcantly
diﬀerent in preeclamptic pregnancies with male and female
fetuses which was in consistence with Steier et al.’s ﬁndings.
Since there is an increment in maternal serum hCG levels
in preeclamptic pregnancies with both male and female
fetuses, so the diﬀerence between them is not clinically
valuable. This ﬁnding suggested that the placenta seems to
play a fundamental role in preeclampsia, as the condition
improves rapidly after its removal. Examination of the
placenta in pregnancies complicated by preeclampsia has
revealedfocalcellularnecrosiswithincreasedmitoticactivity
in the syncytiotrophoblast and cellular proliferation in the
cytotrophoblast. A transformation of the cytotrophoblast
into the syncytiotrophoblast also has been reported [15, 16].
These changes might explain the elevated maternal
serum hCG levels in male-bearing preeclamptic pregnancies,
but there is still no explanation for no increase in maternal
serum hCG levels in female bearing with preeclampsia. In
fact, high maternal serum concentration of hCG in female-
bearing pregnancies is not indicative of preeclampsia since
this increment is also seen in normal pregnancies, whereas,
in male-carrying pregnancies, high maternal serum levels of
hCG can be a marker to predict preeclampsia.
The serum levels of total testosterone increase through-
out normal pregnancy and are primarily a result of pro-
gressive estrogen-induced increase in the concentration
in sex-hormone-binding globulin concentrations [17, 18].
In preeclamptic pregnancies, however, studies have found
lower maternal serum levels of estrogen than in normal
pregnancies, so it is likely that other mechanisms mediate
the maternal serum levels [19, 20]. In the present study, the
maternal serum levels of total testosterone were signiﬁcantly
higher in preeclamptic than in normotensive pregnancies
with male as well as with female fetuses (P<0.001). Male-
bearing preeclamptic pregnancies had signiﬁcantly higher
maternal serum testosterone levels than female-bearing
pregnancies complicated by preeclampsia (P<0.001).
The sources for the increased testosterone levels in
maternalserumareunknownbutcouldbetheovariantheca-
interstitial cells and the maternal cortex, which might be
stimulated by hCG throughout pregnancy. The fetal serum
levelsoftestosteronearemuchlowerthanthematernallevels.
Because of the stimulating eﬀect of hCG on the fetal testis,
the testosterone levels in male fetuses are signiﬁcantly higher
than in female fetuses. The fetal ovaries are regarded asJournal of Pregnancy 5
hormone-ally inactive in the ﬁrst part of pregnancy, but later
they might have steroidogenic capacity [21–23].
In the present study, no correlations were found between
maternal serum levels of hCG and total testosterone. In
uncomplicatedpregnancies,nosigniﬁcantgenderdiﬀerences
were found. The signiﬁcant increase in maternal serum
testosterone levels in preeclamptic pregnancies with male
fetuses as well as with female fetuses, and the signiﬁcantly
higher total testosterone maternal serum levels in male-
than in female-bearing preeclamptic pregnancies were not
related to maternal hCG levels only. In a study in 2006
in Athens, it was found that serum concentrations of
total and free testosterone in preeclamptic pregnancies
are signiﬁcantly higher than in normal pregnancies (P<
0.01) [17]. Some other studies by Carlsen et al., Jirecek et
al., and Gerulewicz et al. also showed increased levels of
androgens in preeclamptic pregnancies in comparison with
normal pregnancies [18–20]. It has been postulated that
preeclampsia could result from a mutation in a paternally
imprinted, maternally active gene. It is also known that only
the paternal allele is expressed in human placenta [24, 25]. A
paternal immunogenetic factor has been suggested, because
signiﬁcantly more preeclampsia is found in pregnancies with
changed paternity [2, 26].
5. Conclusion
Ourﬁndingssuggestthepresenceofanandrogenic-mediated
inﬂuence in the mechanism of preeclampsia. Considering
high prevalence of preeclampsia and its complications on
motherandfetus,mostattemptsarefocusedonpredictionof
the disease using detective indices. According to our results,
there is a correlation between maternal serum hCG and
testosterone levels and preeclampsia. Therefore, these tests
can be used as routine during 30–38 weeks of gestation. High
maternal serum concentrations of these markers can predict
preeclampsia.
References
[1] S. D. Keay, M. Vatish, E. Karteris, E. W. Hillhouse, and H.
S. Randeva, “The role of hCG in reproductive medicine,”
International Journal of Obstetrics and Gynaecology, vol. 111,
no. 11, pp. 1218–1228, 2004.
[2] J. A. Steier, M. Ulstein, and O. L. Myking, “Human chorionic
gonadotropin and testosterone in normal and preeclamptic
pregnancies in relation to fetal sex,” ObstetricsandGynecology,
vol. 100, no. 3, pp. 552–556, 2002.
[3] M. Gol, S. Altunyurt, D. Cimrin, S. Guclu, M. Bagci,
a n dN .D e m i r ,“ D i ﬀerent maternal serum hCG levels in
pregnant women with female and male fetuses: does fetal
hypophyseal—adrenal—gonadal axis play a role?” Journal of
Perinatal Medicine, vol. 32, no. 4, pp. 342–345, 2004.
[4] M.Hines,S.Golombok, J.Rust,K.J.Johnston,and J.Golding,
“Testosterone during pregnancy and gender role behavior of
preschool children: a longitudinal, population study,” Child
Development, vol. 73, no. 6, pp. 1678–1687, 2002.
[5] A. Gurbuz, A. Karateke, M. Mengulluoglu et al., “Can serum
HCG values be used in the diﬀerential diagnosis of pregnancy
complicatedbyhypertension?”HypertensioninPregnancy,vol.
23, no. 1, pp. 1–12, 2004.
[6] Z. Basirat, S. Barat, and M. Hajiahmadi, “Serum beta human
chorionic gonadotropin levels and preeclampsia,” Saudi Med-
ical Journal, vol. 27, no. 7, pp. 1001–1004, 2006.
[7] J. A. Steier, P. B. Bergsjø, T. Thorsen, and O. L. Myking,
“Human chorionic gonadotropin in maternal serum in rela-
tion to fetal gender and utero-placental blood ﬂow,” Acta
Obstetricia et Gynecologica Scandinavica,v o l .8 3 ,n o .2 ,p p .
170–174, 2004.
[8] E. Oral and M. R. Genc ¸, “Hormonal monitoring of the ﬁrst
trimester of pregnancy,” Obstetrics and Gynecology Clinics of
North America, vol. 31, no. 4, pp. 767–778, 2004.
[9] J. A. Steier, O. L. Myking, and P. B. Bergsjø, “Correlation
between fetal sex and human chorionic gonadotropin in
peripheral maternal blood and amniotic ﬂuid in second
and third trimester normal pregnancies,” Acta Obstetricia et
Gynecologica Scandinavica, vol. 78, no. 5, pp. 367–371, 1999.
[10] T. K. Sorensen, M. A. Williams, R. W. Zingheim, S. J.
Clement, and D. E. Hickok, “Elevated second-trimester
human chorionic gonadotropin and subsequent pregnancy-
induced hypertension,” American Journal of Obstetrics and
Gynecology, vol. 169, no. 4, pp. 834–838, 1993.
[ 1 1 ]M .T .A c r o m i t e ,C .S .M a n t z o r o s ,R .E .L e a c h ,J .H u r w i t z ,a n d
L. G. Dorey, “Androgens in preeclampsia,” American Journal of
Obstetrics and Gynecology, vol. 180, no. 1, pp. 60–63, 1999.
[12] M. Gol, S. Guclu, A. Demir, Y. Erata, and N. Demir,
“Eﬀect of fetal gender on maternal serum human chorionic
gonadotropin levels throughout pregnancy,” Archives of Gyne-
cology and Obstetrics, vol. 273, no. 2, pp. 90–92, 2005.
[13] E. Elsm´ en, K. K¨ all´ en, K. Marˇ s´ al, and L. Hellstr¨ om-Westas,
“Fetal gender and gestational-age-related incidence of pre-
eclampsia,” Acta Obstetricia et Gynecologica Scandinavica, vol.
85, no. 11, pp. 1285–1291, 2006.
[14] J. L. Bartha, R. Romero-Carmona, M. Escobar-Llompart, O.
Paloma-Castro, and R. Comino-Delgado, “Human chorionic
gonadotropin and vascular endothelial growth factor in nor-
mal and complicated pregnancies,” Obstetrics and Gynecology,
vol. 102, no. 5, pp. 995–999, 2003.
[15] N. Sageshima, A. Ishitani, M. Omura et al., “Necrotic feature
of the trophoblasts lacking HLA-G expression in normal and
pre-eclamptic placentas,” American Journal of Reproductive
Immunology, vol. 49, no. 3, pp. 174–182, 2003.
[16] G. J. Burton, T. H. Hung, and E. Jauniaux, “Placenta, hypoxia,
hyperoxia and ischemia-reperfusion injury in pre-eclampsia,”
Pre-Eclampsia: Etiology and Clinical Practice, vol. 9, pp. 138–
140, 2007.
[17] E.Salamalekis,P.Bakas,N.Vitoratos,M.Eleptheriadis,andG.
Creatsas, “Androgen levels in the third trimester of pregnancy
in patients with preeclampsia,” European Journal of Obstetrics
Gynecology and Reproductive Biology, vol. 126, no. 1, pp. 16–
19, 2006.
[18] S. M. Carlsen, P. Romunostad, and G. Jacobsen, “Early
second-trimester maternal hyperandrogenemia and subse-
quent preeclampsia: a prospective study,” Acta Obstetricia et
Gynecologica Scandinavica, vol. 84, no. 2, pp. 117–121, 2005.
[19] S. Jirecek, E. A. Joura, C. Tempfer, M. Kn¨ oﬂer, P. Husslein,
and H. Zeisler, “Elevated serum concentrations of androgens
in women with pregnancy-induced hypertension,” Wiener
Klinische Wochenschrift, vol. 115, no. 5-6, pp. 162–166, 2003.
[20] D.Gerulewicz-Vannini,Y.Camero,J.Salas,andE.Hern´ andez-
Andrade, “High androgen plasmatic levels in women aﬀected
with pregnancy-induced hypertension,” Revista de Investiga-
cion Clinica, vol. 58, no. 3, pp. 228–233, 2006.6 Journal of Pregnancy
[21] I. T. Huhtaniemi, C. C. Korenbrot, and R. B. Jaﬀe, “hCG
binding and stimulation of testosterone biosynthesis in the
human fetal testis,” Journal of Clinical Endocrinology and
Metabolism, vol. 44, no. 5, pp. 963–967, 1977.
[22] R. Christine Knickmeyer and S. Baron-Cohen, “Fetal testos-
teroneandsexdiﬀerences,”EarlyHumanDevelopment,vol.82,
no. 12, pp. 755–760, 2006.
[23] C. H. Rodeck, D. Gill, D. A. Rosenberg, and W. P. Collins,
“Testosteronelevelsinmidtrimestermaternalandfetalplasma
and amniotic ﬂuid,” Prenatal Diagnosis, vol. 5, no. 3, pp. 175–
181, 1985.
[24] J.A.MarshallGraves,“Genomicimprinting,developmentand
disease—is pre-eclampsia caused by a maternally imprinted
gene?” Reproduction, Fertility and Development, vol. 10, no. 1,
pp. 23–29, 1998.
[ 2 5 ] S .E .H i b y ,M .L o u g h ,E .B .K e v e r n e ,M .A .S u r a n i ,Y .W .L o k e ,
and A. King, “Paternal monoallelic expression of PEG3 in the
human placenta,” Human Molecular Genetics, vol. 10, no. 10,
pp. 1093–1100, 2001.
[26] J. G. Feeney, “Pre-eclampsia and changed paternity,” in
Pregnancy Hypertention, J. Bonnar, I. MacGillivary, and M.
Symonds, Eds., pp. 41–44, MTP Press limited, Lancaster, UK,
1980.